We are live on ! Find out more
PCM

Pathway Capital Management Portfolio holdings

AUM $4.3M
1-Year Est. Return 62.8%
This Fund
S&P 500
This Quarter Est. Return
-1.42%
1 Year Est. Return
+62.8%
3 Year Est. Return
+496.35%
5 Year Est. Return
+305.57%
10 Year Est. Return
AUM
$209M
AUM Growth
-$43M
Cap. Flow
-$40.1M
Cap. Flow %
-19.2%
Top 10 Hldgs %
88.57%
Holding
34
New
13
Increased
4
Reduced
1
Closed
16

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$57.1M
2
NFLX icon
Netflix
NFLX
+$27.1M
3
NET icon
Cloudflare
NET
+$25.6M
4
MNDY icon
monday.com
MNDY
+$8.97M
5
WRBY icon
Warby Parker
WRBY
+$8.81M

Top Sells

Rank Stock Value
1
DASH icon
DoorDash
DASH
+$52.8M
2
ABNB icon
Airbnb
ABNB
+$22.7M
3
VIR icon
Vir Biotechnology
VIR
+$22.3M
4
COUR icon
Coursera
COUR
+$20.6M
5
PATH icon
UiPath
PATH
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 36.28%
2 Healthcare 33.45%
3 Communication Services 18.24%
4 Financials 5.19%
5 Real Estate 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSPD icon
26
Lightspeed Commerce
LSPD
$1.3B
-73,166
Closed -$6.12M
PATH icon
27
UiPath
PATH
$5.62B
-249,136
Closed -$16.9M
SNOW icon
28
Snowflake
SNOW
$92.9B
-19,976
Closed -$4.83M
TENB icon
29
Tenable Holdings
TENB
$3.56B
-128,504
Closed -$5.31M
UPST icon
30
Upstart Holdings
UPST
$2.58B
-32,780
Closed -$4.09M
VIR icon
31
Vir Biotechnology
VIR
$1.47B
-472,552
Closed -$22.3M
SUMO
32
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-383,387
Closed -$7.92M
RUBY
33
DELISTED
Rubius Therapeutics, Inc
RUBY
-73,667
Closed -$1.8M
EAR
34
DELISTED
Eargo, Inc. Common Stock
EAR
-9,456
Closed -$7.55M

Similar funds

Pathway Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Pathway Capital Management held 34 positions worth $209M, down 17% from $252M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Pathway Capital Management withdrew a net $40.1M in Q3 2021, closing 16 positions and reducing 1 holding. Its most notable exit was DoorDash, an estimated $52.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Pathway Capital Management opened a new position in Denali Therapeutics worth $51.1M.

  • Pathway Capital Management's largest Q3 2021 buy was Denali Therapeutics: 1,012,240 shares worth $51.1M.
  • Pathway Capital Management added most to Datadog in Q3 2021, an estimated $6.2M increase.
  • Pathway Capital Management's biggest Q3 2021 reduction was Roblox, cutting an estimated $2.19M.
  • Pathway Capital Management fully exited DoorDash in Q3 2021, selling an estimated $52.8M.
  • Pathway Capital Management's ten largest holdings make up 89% of its $209M portfolio in Q3 2021.
  • Pathway Capital Management opened 13 new positions and closed 16 in Q3 2021.
  • Pathway Capital Management's portfolio value fell 17% quarter-over-quarter to $209M.

Based on Pathway Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.